N-cyclopropyl-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide → N-cyclopropyl-4-methyl-3-(3-(piperidin-4-yl)benzo[d]isoxazol-6-yl)benzamide
反応式
Br[C:2]1[CH:16]=[CH:15][C:5]2[C:6]([CH:9]3[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]3)=[N:7][O:8][C:4]=2[CH:3]=1.[CH:17]1([NH:20][C:21](=[O:38])[C:22]2[CH:27]=[CH:26][C:25]([CH3:28])=[C:24](B3OC(C)(C)C(C)(C)O3)[CH:23]=2)[CH2:19][CH2:18]1>>[CH:17]1([NH:20][C:21](=[O:38])[C:22]2[CH:27]=[CH:26][C:25]([CH3:28])=[C:24]([C:2]3[CH:16]=[CH:15][C:5]4[C:6]([CH:9]5[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]5)=[N:7][O:8][C:4]=4[CH:3]=3)[CH:23]=2)[CH2:18][CH2:19]1参加物
3
実験手順
Example 1 was prepared by General Method A using 6-bromo-3-piperidin-4-yl-1,2-benzisoxazole and Intermediate 5.
出典と根拠
- ORDレコード
- ord-4c5006fbaf44450bae7010a80b2897a0
- 出典データセット
- uspto-grants-2010_01
- 特許番号
- US07642276B2
反応ノート
読み込み中…